{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:21:55Z","timestamp":1790878915029,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Arbor Research Collaborative for Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The use of diuretics in patients on haemodialysis (HD) is thought to maintain diuresis. However, this assumption and the optimal dose are based on little scientific evidence, and associations with clinical outcomes are unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reported international variations in diuretic use and loop diuretic dose across 27\u00a0759 HD patients with dialysis vintage &amp;lt;1\u00a0year in the Dialysis Outcomes and Practice Patterns Study phases 2\u20135 (2002\u20132015), a prospective cohort study. Doses of torsemide (4:1) and bumetanide (80:1) were converted to oral furosemide-equivalent doses. Adjusted Cox, logistic and linear regressions were used to investigate the association of diuretic use and dose with outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Diuretic utilization varied widely by country at vintage &amp;lt;3\u00a0months, ranging from &amp;gt;80% in Germany and Sweden to &amp;lt;35% in the USA, at a median dose ranging from 400\u2013500\u00a0mg\/day in Germany and Sweden to &amp;lt;100\u00a0mg\/day in Japan and the USA. Neither diuretic use nor higher doses were associated with a lower risk of all-cause mortality, a higher risk of hospitalization for fracture or elevated parathyroid hormone levels, but the prescription of higher doses (&amp;gt;200\u00a0mg\/day) was associated with a higher risk of all-cause hospitalization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Substantial international differences exist in diuretic prescriptions, with use and doses much higher in some European countries than the USA. The prescription and higher doses of loop diuretics was not associated with improved outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae141","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T04:46:22Z","timestamp":1718426782000},"source":"Crossref","is-referenced-by-count":5,"title":["Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-0163","authenticated-orcid":false,"given":"Nahid","family":"Tabibzadeh","sequence":"first","affiliation":[{"name":"Nephrology Division, Massachusetts General Hospital , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Karaboyas","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schaeffner","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Institute of Public Health, Charit\u00e9-Universit\u00e4tsmedizin Berlin , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Vega","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women's Medical University , Shinjuku, Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bieber","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-1906","authenticated-orcid":false,"given":"Pablo Antonio Ure\u00f1a","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Dialysis, AURA Nord Saint Ouen , Saint-Ouen , France"},{"name":"Department of Renal Physiology, Necker Hospital, University of Paris Descartes , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"2024071008262303700_bib1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2215\/CJN.10611015","article-title":"Antihypertensive medication use in older patients transitioning from chronic kidney disease to end-stage renal disease on dialysis","volume":"11","author":"Chang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024071008262303700_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","article-title":"Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary","volume":"79","author":"Al-Makki","year":"2022","journal-title":"Hypertension"},{"issue":"5 Suppl 1","key":"2024071008262303700_bib3","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","author":"Kidney Disease Outcomes Quality Initiative","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"2024071008262303700_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1525-139X.2011.00927.x","article-title":"Should high-dose oral diuretics be used to increase urine output in patients on chronic peritoneal and hemodialysis?","volume":"24","author":"Fissell","year":"2011","journal-title":"Semin Dial"},{"key":"2024071008262303700_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00041552-200309000-00001","article-title":"Diuretic use in stage 5 chronic kidney disease and end-stage renal disease","volume":"12","author":"Sica","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2024071008262303700_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/sdi.12483","article-title":"Are diuretics underutilized in dialysis patients?","volume":"29","author":"Trinh","year":"2016","journal-title":"Semin Dial"},{"key":"2024071008262303700_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","article-title":"Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis","volume":"119","author":"Kalantar-Zadeh","year":"2009","journal-title":"Circulation"},{"key":"2024071008262303700_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","article-title":"Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"69","author":"Karaboyas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2215\/CJN.04451206","article-title":"Serum and dialysate potassium concentrations and survival in hemodialysis patients","volume":"2","author":"Kovesdy","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024071008262303700_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.ajkd.2010.03.020","article-title":"Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study","volume":"56","author":"Shafi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib12","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/ndt\/gfn707","article-title":"The mortality risk of overhydration in haemodialysis patients","volume":"24","author":"Wizemann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2024071008262303700_bib13","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1046\/j.1523-1755.1998.00181.x","article-title":"Augmenting solute clearance in peritoneal dialysis","volume":"54","author":"Krediet","year":"1998","journal-title":"Kidney Int"},{"key":"2024071008262303700_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10157-011-0427-z","article-title":"Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis","volume":"15","author":"Lemes","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"2024071008262303700_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000168471","article-title":"Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients","volume":"12","author":"van Olden","year":"1992","journal-title":"Am J Nephrol"},{"key":"2024071008262303700_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrneph.2011.175","article-title":"Diuretic use in renal disease","volume":"8","author":"Sica","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"2024071008262303700_bib17","article-title":"Fiche info\u2014LASILIX SPECIAL 500\u00a0mg, comprim\u00e9 s\u00e9cable\u2014Base de donn\u00e9es publique des m\u00e9dicaments"},{"key":"2024071008262303700_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","article-title":"Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis","volume":"59","author":"Medcalf","year":"2001","journal-title":"Kidney Int"},{"key":"2024071008262303700_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ajkd.2006.12.012","article-title":"Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS)","volume":"49","author":"Bragg-Gresham","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2215\/CJN.05080418","article-title":"Association of continuation of loop diuretics at hemodialysis initiation with clinical outcomes","volume":"14","author":"Sibbel","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024071008262303700_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","article-title":"Fracture risk in patients treated with loop diuretics","volume":"259","author":"Rejnmark","year":"2006","journal-title":"J Intern Med"},{"key":"2024071008262303700_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2362.2003.01103.x","article-title":"Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women","volume":"33","author":"Rejnmark","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"2024071008262303700_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology","volume":"44","author":"Pisoni","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 74","key":"2024071008262303700_bib24","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1046\/j.1523-1755.2000.07413.x","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study","volume":"57","author":"Young","year":"2000","journal-title":"Kidney Int"},{"key":"2024071008262303700_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2024071008262303700_bib26","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/sim.6404","article-title":"On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication","volume":"34","author":"Li","year":"2015","journal-title":"Stat Med"},{"key":"2024071008262303700_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.ajkd.2014.05.025","article-title":"Practice-based versus patient-level outcomes research in hemodialysis: the DOPPS (Dialysis Outcomes and Practice Patterns Study) experience","volume":"64","author":"Port","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib28","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.ajkd.2020.05.019","article-title":"Community racial composition and hospitalization among patients receiving in-center hemodialysis","volume":"76","author":"Golestaneh","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib29","doi-asserted-by":"crossref","first-page":"100520","DOI":"10.1016\/j.xkme.2022.100520","article-title":"Diuretic use among patients receiving hemodialysis in the United States","volume":"4","author":"Flythe","year":"2022","journal-title":"Kidney Med"},{"key":"2024071008262303700_bib30","doi-asserted-by":"crossref","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","article-title":"Everything we always wanted to know about furosemide but were afraid to ask","volume":"310","author":"Huang","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024071008262303700_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","article-title":"EDHD resistance","volume":"69","author":"Hoorn","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2024071008262303700_bib32","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ekir.2022.07.003","article-title":"Efficacy, safety, and tolerability of oral furosemide among patients receiving hemodialysis: a pilot study","volume":"7","author":"Flythe","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2024071008262303700_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ekir.2022.10.025","article-title":"Use of oral furosemide in hemodialysis","volume":"8","author":"Siga","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2024071008262303700_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2024071008262303700_bib35","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2215\/CJN.08310722","article-title":"Effect of furosemide on proximal tubular secretion of organic solutes in patients receiving hemodialysis","volume":"17","author":"Sirich","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024071008262303700_bib36","doi-asserted-by":"crossref","first-page":"ii106","DOI":"10.1093\/ndt\/gfw287","article-title":"Understanding associations of hemodialysis practices with clinical and patient-reported outcomes: examples from the DOPPS","volume":"32","author":"Port","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2024071008262303700_bib37","first-page":"56","article-title":"Loop diuretics in acute decompensated heart failure","volume-title":"Circ Heart Fail","author":"Felker","year":"2009"},{"key":"2024071008262303700_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/fcp.12533","article-title":"Drug-induced hearing loss: a case\/non-case study in the French pharmacovigilance database","volume":"34","author":"Favreli\u00e8re","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"2024071008262303700_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/gerona\/glz166","article-title":"The contribution of ototoxic medications to hearing loss among older adults","volume":"75","author":"Joo","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024071008262303700_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.joto.2016.10.001","article-title":"Ototoxic effects and mechanisms of loop diuretics","volume":"11","author":"Ding","year":"2016","journal-title":"J Otol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae141\/58238435\/sfae141.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/7\/sfae141\/58489586\/sfae141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/7\/sfae141\/58489586\/sfae141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T08:28:57Z","timestamp":1720600137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae141\/7693744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae141","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,14]]},"article-number":"sfae141"}}